Screening for ovarian cancer: U.S. Preventive services task force reaffirmation recommendation statement

Annals of Internal Medicine

Volumn 157, Issue 12, 2012, Pages 900-904

  Moyer, Virginia A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BRCA1 PROTEIN; BRCA2 PROTEIN; CA 125 ANTIGEN;

BREAST CANCER; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CYTOREDUCTIVE SURGERY; EARLY INTERVENTION; FAMILY HISTORY; GENE MUTATION; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; LAPAROSCOPY; LAPAROTOMY; ONCOGENE; OVARIECTOMY; OVARY CANCER; PALPATION; PELVIC EXAMINATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TRANSVAGINAL ECHOGRAPHY;

EID: 84867136524     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-157-11-201212040-00539     Document Type: Review

References (14)

1. Nelson HD, Westhoff C, Piepert J, Berg A. Screening for Ovarian Cancer: Brief Evidence Update. AHRQ Publication no. 04-0542-B. Rockville, MD: Agency for Healthcare Research and Quality; May 2004. Accessed at www.uspreventiveservicestaskforce.org/3rduspstf/ovariancan/ovcanup.htm on 30 August 2012.
2. Barton MB, Lin K. Screening for Ovarian Cancer: Evidence Update for the U.S. Preventive Services Task Force Reaffirmation Recommendation Statement. AHRQ Publication no. 12-05165-EF3. Rockville, MD: Agency for HealthcareResearch and Quality; April 2012. Accessed at www.uspreventiveservicestaskforce.org/uspstf12/ovarian/ovarart.htm on 30 August 2012.
3. Danforth KN, Im TM, Whitlock EP. Addendum to Screening for Ovarian Cancer: Evidence Update for the U.S. Preventive Services Task Force Reaffirmation Recommendation Statement. AHRQ Publication no. 12-05165-EF4. Rockville, MD: Agency for Healthcare Research and Quality; April 2012. Accessed at www.uspreventiveservicestaskforce.org/uspstf12/ovarian/ovarartaddend.htm on 30 August 2012.
4. Buys SS, Partridge E, Black A, Johnson CC, Lamerato L, Isaacs C, et al; PLCO Project Team. Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening randomized controlled trial. JAMA. 2011;305:2295-303. [PMID: 21642681]
5. Partridge E, Kreimer AR, Greenlee RT, Williams C, Xu JL, Church TR, et al; PLCO Project Team. Results from four rounds of ovarian cancer screening in a randomized trial. Obstet Gynecol. 2009;113:775-82. [PMID: 19305319]
6. Kobayashi H, Yamada Y, Sado T, Sakata M, Yoshida S, Kawaguchi R, et al. A randomized study of screening for ovarian cancer: a multicenter study in Japan. Int J Gynecol Cancer. 2008;18:414-20. [PMID: 17645503]
7. Menon U, Skates SJ, Lewis S, Rosenthal AN, Rufford B, Sibley K, et al. Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer. J Clin Oncol. 2005;23:7919-26. [PMID: 16258091]
8. Menon U, Gentry-Maharaj A, Hallett R, Ryan A, Burnell M, Sharma A, et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol. 2009;10:327-40. [PMID: 19282241]
9. Arrayit Corporation announces premarket approval (PMA) submission strategy for OvaDx [Press release]. Sunnyvale, CA: Globe Newswire; 23 August 2010. Accessed at www.globenewswire.com/newsroom/news.html?d_199862 on 30 August 2012.
10. Rufford BD, Jacobs IJ, Menon U. Feasibility of screening for ovarian cancer using symptoms as selection criteria. BJOG. 2007;114:59-64. [PMID: 17233861]
11. Gilbert L, Basso O, Sampalis J, Karp I, Martins C, Feng J, et al; DOvE Study Group. Assessment of symptomatic women for early diagnosis of ovarian cancer: results from the prospective DOvE pilot project. Lancet Oncol. 2012;13: 285-91. [PMID: 22257524]
12. Goff BA, Mandel LS, Melancon CH, Muntz HG. Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA. 2004;291: 2705-12. [PMID: 15187051]
13. American College of Obstetricians and Gynecologists Committee on Gynecologic Practice. Committee Opinion No. 477: the role of the obstetriciangynecologist in the early detection of epithelial ovarian cancer. Obstet Gynecol. 2011;117:742-6. [PMID: 21343791]
14. American Cancer Society. Cancer Facts & Figure 2012. Atlanta: American Cancer Soc; 2012. Accessed at www.cancer.org/Research/CancerFactsFigures/CancerFactsFigures/cancer-facts-figures-2012 on 2 April 2012.